Oncobiologics announced that Lawrence A. Kenyon, its chief financial officer and corporate secretary, has been appointed to the role of president and chief executive officer, and has joined the Company’s Board of Directors as a class II director. Mr. Kenyon will remain as chief financial officer until a replacement is appointed. “On behalf of the Oncobiologics board of directors, we are very pleased to name Larry as President and CEO as well as his appointment to the board of directo...